Abstract
Context
Aminoglycosides, as potent bactericidal antibiotics against aerobic gram-negative infections, is still widely used, especially in NICU patients, despite their known potential ototoxic effects.
Aims
To evaluate the potential of transient evoked otoacoustic emissions (TEOAEs) in early identification of decreased hearing sensitivity in hospitalized neonates receiving aminoglycosides for severe gram-negative infections.
Materials and Methods
Fifty (50) neonates treated with intravenous gentamicin (5 mg/kg/day) or amikacin (15 mg/kg/day) were tested with TEOAE in the beginning and the end of aminoglycoside therapeutic course. There were 23 males and 27 females, ranging from 29 to 40 weeks (mean: 36 weeks). The treatment duration was 3–30 days (in 26 neonates up to 7 days — group A, and in 24 neonates higher than 7 days — group B).
Results
In group A, no statistically significant difference in the mean response level was found between the onset and the end of treatment course (p > 0.001).
In group B, a statistically significant difference in the mean response level was found between the onset and the end of treatment course, especially at high frequency region (p < 0.001).
Conclusions
TEOAE is sensitive enough to detect early aminoglycoside ototoxicity. As this test is simple to perform, non-invasive and reliable, so we suggest that TEOAE test should be performed in NICU as routine for monitoring cochlear function to prevent permanent hearing loss especially in those who are receiving aminoglycoside for more than 7 days.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kahlmeter G, Dahlager JI (1984) Aminoglycoside toxicity — a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother 13(Suppl A):9–22 [Medline]
Mayers RE (1970) Ototoxic effects of gentamicin. Arch Laryngol 92:160–162
Stravroulaki P, Apostolopoulos N, Dinopoulou D, Vossinakis I, Tsakanios M, Douniadakis D (1999) Otoacoustic emissions — an approach for monitoring aminoglycoside induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 50(3):177–184
Probst R, Smuizynski J, Schmuziger N (2005) Otoacoustic emissions and extended high frequency hearinh sensitivity in young adults. Int J Audiol 44(1):24–30
Hawkins JE, Lurie MH (1953) The ototoxicity of dihydrostreptomycin and neomycin in cat. Ann Otol Rhinol Laryngol 62:1128–1148
Lim DJ (1976) Ultrastructural cochlear changes following acoustic hyper-stimulation and ototoxicity. Ann Otol Rhinol Laryngol 85:740–751
Hunter-Duvar IM, Mount RJ (1978) The organ of Corti following ototoxic antibiotic treatment. Scanning Electron Microsc 2:423–430
Harrison RV, Evans EF (1979) Cochlear fibre responses in guinea pigs with well defined cochlear lesions. Scand Audiol Suppl 9:83–92
Mountain DC (1986) Electromechanical properties of hair cells. In: Altschuler RA, Hoffman DW, Bobbin RP (Eds.), Neurobiology of Hearing: The Cochlea. New York, Raven Press, pp 77–90
Brown AM, McDowell B, Forge A (1989) Acoustic distortion products can be used to monitor the effects of chronic gentamicin treatment. Hear Res 42:143–156
Lonsbury-Martin BL, Martin GK, Probst R, Coats AC (1987) Acoustic distortion products in rabbit ear canal. I. Basic features and physiological vulnerability. Hear Res 28:173–189
Martin GK, Lonsbury-Martin BL, Probst R, Scheinin SA, Coats AC (1987) Acoustic distortion products in rabbit ear canal. II. Sites of origin revealed by suppression contours and pure-tone exposures. Hear Res 28:191–208
Zorowka P, Schmitt HJ, Eckel HE, Lippert KL, Schonberger W, Merz E (1993) Serial measurements of tranient evoked otoacoustic emissions (TEOAEs) in healthy newborns and in newborns with perinatal infection. Int J Pediatr Otorhinolaryngol 27:245–254
Hotz MA, Harris FP, Probst R (1994) Otoacoustic emissions: An approach for monitoring aminoglycoside-induced ototoxicity. Laryngoscope 104:1130–1134
Henley CM, Rybak LP (1995) Ototoxicity in developing mammals. Brain Res Rev 20:68–90
Henley CM, Weatherly RA, Martin GK, Lonsbury-Martin BL (1996) Sensitive developmental periods for kanamicin ototoxicity effects on distortion-product otoacoustic emissions. Hear Res 98:93–103
Kakigi A, Hirakawa H, Harel N, Mount RJ, Harrison RV (1998) Basal Cochlear Lesions Result in Increased Amplitude of Otoacoustic Emissions. Audiol Neurootol 3:361–372
Probst R, Lonsbury-Martin BL, Martin GK (1991) A review of otoacoustic emissions. J Acoust Soc Am 89:2027–2067
Kemp DT (1988) Development in cochlear mechanism and techniques for noninvasive evaluation. Adv Audiol 5:27–45
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naeimi, M., Maamouri, G., Boskabadi, H. et al. Assessment of aminoglycoside-induced hearing impairment in hospitalized neonates by TEOAE. Indian J Otolaryngol Head Neck Surg 61, 256–261 (2009). https://doi.org/10.1007/s12070-009-0078-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-009-0078-5